Incyte Corp (NASDAQ:INCY)

CAPS Rating: 2 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar TerryHoodSr (57.40) Submitted: 5/27/2013 2:55:54 PM : Outperform Start Price: $20.88 INCY Score: -6.63

2014 EPS growth

Featured Broker Partners


Advertisement